Clinical Trial Update: Prevention of Metabolic Complications of Glucocorticoid Excess [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on preventing metabolic complications of glucocorticoid excess in iatrogenic Cushing syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iatrogenic Cushing Disease

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Iatrogenic Cushing Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-04-12